2025 Journal Article Schrödinger's cat and mouse: An adapted thought experiment for the context of consciousnessEeles, Eamonn, Pourzinal, Dana, Baland, Jalal and Ray, Julian (2025). Schrödinger's cat and mouse: An adapted thought experiment for the context of consciousness. Behavioural Brain Research, 483 115459, 115459. doi: 10.1016/j.bbr.2025.115459 |
2024 Journal Article Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD dataPourzinal, Dana, Lawson, Rachael A., Yarnall, Alison J., Williams‐Gray, Caroline H., Barker, Roger A., Yang, Jihyun, McMahon, Katie L., O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2024). Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 16 (3) e12625, 1-11. doi: 10.1002/dad2.12625 |
2024 Conference Publication Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare projectAu, T., Bailey, D., Beattie, E., Brooks, D., Broome, A., Byrne, G., Chatfield, M., Dissanayaka, N., Keramat, S.A., Lehn, A., Liddle, J., Marsh, R., Mitchell, L., Naismith, S., Nestor, S., O’Sullivan, J., Pachana, N., Pourzinal, D., Robertson, S., Shrubsole, K., Sivakumaran, K., Spooner, D., Tinson, H., Verreynne, M.L., Worthy, P. and Yang, J. (2024). Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare project. Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024. |
2024 Conference Publication Neuropsychological predictors of cognitive decline in Parkinson's disease: A systematic review (PDCogniCare)Pourzinal, D., Sivakumaran, K., Yang, J., Bailey, D.X., Mitchell, L.K., Brooks, D. and Dissanayaka, N. (2024). Neuropsychological predictors of cognitive decline in Parkinson's disease: A systematic review (PDCogniCare). Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024. |
2024 Journal Article Telehealth cognitive behavior therapy to reduce anxiety in people living with cognitive impairment: a randomized feasibility pilot studyPacas Fronza, Gabriela, Mitchell, Leander K., Pachana, Nancy A., Byrne, Gerard J., Liddle, Jacki, Yang, Jihyun, Brooks, Deborah, Au, Tiffany, Pourzinal, Dana, Worthy, Peter, Comans, Tracy, Beattie, Elizabeth, Bennett, Sally, Russell, Trevor and Dissanayaka, Nadeeka N. (2024). Telehealth cognitive behavior therapy to reduce anxiety in people living with cognitive impairment: a randomized feasibility pilot study. Clinical Gerontologist, 1-15. doi: 10.1080/07317115.2024.2336187 |
2024 Journal Article Hippocampal resting‐state connectivity is associated with posterior‐cortical cognitive impairment in Parkinson's diseasePourzinal, Dana, Yang, Jihyun, McMahon, Katie L., Copland, David A., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2024). Hippocampal resting‐state connectivity is associated with posterior‐cortical cognitive impairment in Parkinson's disease. Brain and Behavior, 14 (3) e3454, 1-12. doi: 10.1002/brb3.3454 |
2024 Conference Publication Verbal fluency correlates with medial temporal lobe volumes in Parkinson’s disease with memory impairmentYang, J., Pourzinal, D. and Dissanayaka, N. (2024). Verbal fluency correlates with medial temporal lobe volumes in Parkinson’s disease with memory impairment. Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024. |
2023 Journal Article Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocolDissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y |
2023 Other Outputs Cognitive subtypes in Parkinson’s disease: exploring phenotypes, neuroimaging targets, and therapeuticsPourzinal, Dana (2023). Cognitive subtypes in Parkinson’s disease: exploring phenotypes, neuroimaging targets, and therapeutics. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/063c937 |
2023 Journal Article Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's diseasePourzinal, Dana, Yang, Jihyun, Sivakumaran, Kumareshan, McMahon, Katie L., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2023). Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease. Brain and Behavior, 13 (10) e3218, e3218. doi: 10.1002/brb3.3218 |
2023 Journal Article Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's diseaseYang, Jihyun, Pourzinal, Dana, Byrne, Gerard J., McMahon, Katie L., Copland, David A., O’Sullivan, John D., Mitchell, Leander and Dissanayaka, Nadeeka N. (2023). Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease. International Journal of Geriatric Psychiatry, 38 (6) e5955, e5955. doi: 10.1002/gps.5955 |
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Centre for Clinical Research HDR Symposium, Brisbane, QLD Australia, 24 November 2022. |
2022 Journal Article Systematic review of data‐driven cognitive subtypes in Parkinson’s diseasePourzinal, Dana, Yang, Jihyun, Lawson, Rachael A., McMahon, Katie L., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2022). Systematic review of data‐driven cognitive subtypes in Parkinson’s disease. European Journal of Neurology, 29 (11), 3395-3417. doi: 10.1111/ene.15481 |
2022 Journal Article Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairmentYang, Jihyun, McMahon, Katie L., Copland, David A., Pourzinal, Dana, Byrne, Gerard J., Angwin, Anthony J., O’Sullivan, John D. and Dissanayaka, Nadeeka N (2022). Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment. Brain Imaging and Behavior, 16 (6), 1-12. doi: 10.1007/s11682-022-00698-7 |
2022 Journal Article The Attention Network Test in Parkinson and Lewy body disease: a systematic reviewYang, Jihyun, Pourzinal, Dana, Rheinberger, Toby, Copland, David A., McMahon, Katie L., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2022). The Attention Network Test in Parkinson and Lewy body disease: a systematic review. Cognitive and Behavioral Neurology, 35 (1), 1-13. doi: 10.1097/WNN.0000000000000292 |
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Neurosciences Symposium, Brisbane, QLD Australia, 26-27 September 2022. |
2022 Conference Publication Functional magnetic resonance imaging of the hippocampus as biomarker for cognitive decline in Parkinson’s diseasePourzinal, D., Yang, J., Byrne, G.J., O’Sullivan, J.D., McMahon, K. and Dissanayaka, N. (2022). Functional magnetic resonance imaging of the hippocampus as biomarker for cognitive decline in Parkinson’s disease. UQ Faculty of Medicine HDR Student Symposium, Brisbane, QLD, Australia, 7 October 2022. |
2021 Journal Article Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementiaDissanayaka, Nadeeka N., Forbes, Elana J., Yang, Ji Hyun J., Pourzinal, Dana, O’Sullivan, John D., Mitchell, Leander K., Copland, David A., McMahon, Katie L. and Byrne, Gerard J. (2021). Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia. Journal of Neurology, 269 (3), 1600-1609. doi: 10.1007/s00415-021-10736-x |
2021 Journal Article Hippocampal correlates of episodic memory in Parkinson's disease: A systematic review of magnetic resonance imaging studiesPourzinal, Dana, Yang, Ji Hyun J., Bakker, Arnold, McMahon, Katie L., Byrne, Gerard J., Pontone, Gregory M., Mari, Zoltan and Dissanayaka, Nadeeka N. (2021). Hippocampal correlates of episodic memory in Parkinson's disease: A systematic review of magnetic resonance imaging studies. Journal of Neuroscience Research, 99 (9) jnr.24863, 2097-2116. doi: 10.1002/jnr.24863 |
2021 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J., Adam, R., Copland, D., Yang, J.H.J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2021). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocol. Australia Dementia Forum 2021, Online, 31 May - 1 June 2021. |